Form D · Biotechnology
Vitro Biopharma, Inc.
Golden, CO · CIK 0000793171
Offering snapshot reported Jun 11, 2025 · SEC filing
- Reported sold
- $100K Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2025 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Dec 1, 2023 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Apr 5, 2023 | Amendment | $992,600 | $587,600vs Jan 23, 2023 | 9 | SEC filing |
| Jan 23, 2023 | Initial | $405,000 | No comparison | 5 | SEC filing |
| Oct 20, 2021 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Oct 8, 2020 | Amendment | $1,000,000 | $500,000vs Jan 23, 2020 | 10 | SEC filing |
| Jan 23, 2020 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Sep 30, 2010 | Initial | $30,000 | No comparison | 2 | SEC filing |
| Jan 6, 2010 | Initial | $87,500 | No comparison | 3 | SEC filing |
| Feb 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548679
Source: Form D, filed Jun 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Evans | Director |
| Chris Furman | Director, Executive |
| Christopher Furman | Director, Executive |
| Nathan Haas | Executive |
| Caroline Mosessian | Director |
| James Musick | Director |
| Thomas Ohrt | Executive |
| John Packs | Director |
| Tiana States | Executive |
| Erik Van Horn | Director |
| Jack Zamora | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4621 Technology Dr.
Golden, CO, 80403
Golden, CO, 80403